As of September 2024, Synmosa Biopharma Corporation has a market cap of $455.93M. This makes Synmosa Biopharma Corporation the world's 11955th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $470.52M | 0.13% |
2023 | $469.91M | -20.64% |
2022 | $592.10M | 106.36% |
2021 | $286.93M | 3.74% |
2020 | $276.59M | 12.66% |
2019 | $245.50M | -1.61% |
2018 | $249.52M | 16.59% |
2017 | $214.01M | -3.81% |
2016 | $222.49M | -8.37% |
2015 | $242.82M | -4.58% |
2014 | $254.48M | 14.42% |
2013 | $222.41M | 4.99% |
2012 | $211.84M | 60.06% |
2011 | $132.35M | -22.07% |
2010 | $169.84M | -7.60% |
2009 | $183.81M | 84.56% |
2008 | $99.59M | -27.89% |
2007 | $138.11M | - |